Search Count: 8
 |
Aalall Segment From The Nucleoprotein Of Sars-Cov-2, Residues 217-222, Crystal Form 1
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2021-03-17 Classification: PROTEIN FIBRIL Ligands: TFA |
 |
Aalall Segment From The Nucleoprotein Of Sars-Cov-2, Residues 217-222, Crystal Form 2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-03-17 Classification: PROTEIN FIBRIL Ligands: PG4 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.10 Å Release Date: 2021-03-17 Classification: PROTEIN FIBRIL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-03-17 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2019-11-13 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: ORO, FMN, SO4, M4J |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2019-11-13 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: ORO, FMN, PO4, 1SU |
 |
Human Dck C4S-S74E Mutant In Complex With Udp And The F2.2.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3-Thiazol-4-Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2013-09-18 Classification: transferase/transferase inhibitor Ligands: UDP, 1NO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2013-09-18 Classification: transferase/transferase inhibitor Ligands: 1UX, UDP |